NCT00255723View on ClinicalTrials.gov

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Lymphoma
Interventions
DRUG

carboplatin

Given IV

DRUG

etoposide

Given IV

DRUG

ifosfamide

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00255723 - Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter